Emily Mui
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus
- Antifungal resistance and susceptibility
Papers in
-
- Pneumonia and Respiratory Infections 3
-
- Antimicrobial Resistance in Staphylococcus 4
- Antifungal resistance and susceptibility 3
- Co-authors
- Marisa Holubar (16 shared papers)Lina Meng (9 shared papers)Stan Deresinski (10 shared papers)Tiffany Wong (1 shared paper)Sharon Huang (1 shared paper)Lindsey R. Baden (1 shared paper)Julie M. Bryar (1 shared paper)Francisco M. Marty (1 shared paper)
- Journals
- Open Forum Infectious Diseases (10 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (3 papers)ACS Chemical Biology (1 paper)Journal of Clinical Microbiology (1 paper)Clinical Therapeutics (1 paper)
- Partner nations
- United StatesIndia
In The Last Decade
Emily Mui
19 papers receiving 322 citations
Peers
Comparison fields: 5 of 72
- Applied Microbiology and Biotechnology 40
- Infectious Diseases 135
- Clinical Biochemistry 48
- Pharmacology 113
- Molecular Medicine 18
Countries citing papers authored by Emily Mui
This map shows the geographic impact of Emily Mui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Mui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Mui more than expected).
Fields of papers citing papers by Emily Mui
This network shows the impact of papers produced by Emily Mui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Mui. The network helps show where Emily Mui may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily Mui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 118 | |
| 2 | 2019 | 77 | |
| 3 | 2010 | 50 | |
| 4 | 2023 | 23 | |
| 5 | 2020 | 16 | |
| 6 | 2021 | 12 | |
| 7 | 2022 | 12 | |
| 8 | 2022 | 8 | |
| 9 | 2016 | 3 | |
| 10 | 2019 | 2 | |
| 11 | 2024 | 1 | |
| 12 | 2024 | 1 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2019 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2014 | 1 | |
| 20 | 2020 | 1 |
About Emily Mui
Emily Mui is a scholar working on Epidemiology, Infectious Diseases, Pharmacology, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 22 papers that have together received 331 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (7 papers), Bacterial Identification and Susceptibility Testing (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Antifungal resistance and susceptibility (3 papers), Pneumonia and Respiratory Infections (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers) and Patient Satisfaction in Healthcare (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (40 citations), Infectious Diseases (135 citations), Clinical Biochemistry (48 citations), Pharmacology (113 citations) and Molecular Medicine (18 citations). Emily Mui has collaborated with scholars based in United States and India. Frequent co-authors include Marisa Holubar, Lina Meng, Stan Deresinski, Tiffany Wong, Sharon Huang, Lindsey R. Baden, Julie M. Bryar, Francisco M. Marty, Anne McDonnell and David W. Kubiak. Their work appears in journals such as Open Forum Infectious Diseases, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, ACS Chemical Biology, Journal of Clinical Microbiology and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.